Year |
Citation |
Score |
2018 |
Shu Y, Yin H, Rajabi M, Li H, Vieweger M, Guo S, Shu D, Guo P. RNA-based micelles: A novel platform for chemotherapeutic drug loading and delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29454064 DOI: 10.1016/J.Jconrel.2018.02.014 |
0.422 |
|
2016 |
Zhang Y, Leonard M, Shu Y, Yang Y, Shu D, Guo P, Zhang X. Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing using Multifunctional pRNA Nanoparticles. Acs Nano. PMID 27966906 DOI: 10.1021/Acsnano.6B05910 |
0.393 |
|
2016 |
Binzel DW, Shu Y, Li H, Sun M, Zhang Q, Shu D, Guo B, Guo P. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27125502 DOI: 10.1038/Mt.2016.85 |
0.417 |
|
2015 |
Shu D, Li H, Shu Y, Xiong G, Carson WE, Haque F, Xu R, Guo P. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. Acs Nano. PMID 26387848 DOI: 10.1021/Acsnano.5B02471 |
0.436 |
|
2015 |
Cui D, Zhang C, Liu B, Shu Y, Du T, Shu D, Wang K, Dai F, Liu Y, Li C, Pan F, Yang Y, Ni J, Li H, Brand-Saberi B, et al. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA. Scientific Reports. 5: 10726. PMID 26137913 DOI: 10.1038/Srep10726 |
0.411 |
|
2015 |
Rychahou P, Shu Y, Haque F, Hu J, Guo P, Evers BM. Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases. Methods in Molecular Biology (Clifton, N.J.). 1297: 121-35. PMID 25896000 DOI: 10.1007/978-1-4939-2562-9_9 |
0.467 |
|
2015 |
Rychahou P, Haque F, Shu Y, Zaytseva Y, Weiss HL, Lee EY, Mustain W, Valentino J, Guo P, Evers BM. Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. Acs Nano. 9: 1108-16. PMID 25652125 DOI: 10.1021/Acsnano.5B00067 |
0.424 |
|
2014 |
Shu Y, Pi F, Sharma A, Rajabi M, Haque F, Shu D, Leggas M, Evers BM, Guo P. Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Advanced Drug Delivery Reviews. 66: 74-89. PMID 24270010 DOI: 10.1016/J.Addr.2013.11.006 |
0.454 |
|
2013 |
Shu Y, Shu D, Haque F, Guo P. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nature Protocols. 8: 1635-59. PMID 23928498 DOI: 10.1038/Nprot.2013.097 |
0.439 |
|
2013 |
Zhang H, Endrizzi JA, Shu Y, Haque F, Sauter C, Shlyakhtenko LS, Lyubchenko Y, Guo P, Chi YI. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA. Rna (New York, N.Y.). 19: 1226-37. PMID 23884902 DOI: 10.1261/Rna.037077.112 |
0.314 |
|
2013 |
Shu Y, Haque F, Shu D, Li W, Zhu Z, Kotb M, Lyubchenko Y, Guo P. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. Rna (New York, N.Y.). 19: 767-77. PMID 23604636 DOI: 10.1261/Rna.037002.112 |
0.47 |
|
2013 |
Rychahou P, Shu Y, Simonelli F, Zaytseva Y, Elliott VA, Lee E, Weiss HL, Mustain WC, Valentino J, Guo P, Evers BM. Tu1890 Targeting Colorectal Cancer Liver Metastases With Folate-Conjugated Ultrastable RNA Nanoparticles Gastroenterology. 144: S-873. DOI: 10.1016/S0016-5085(13)63247-3 |
0.414 |
|
2012 |
Haque F, Shu D, Shu Y, Shlyakhtenko LS, Rychahou PG, Evers BM, Guo P. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today. 7: 245-257. PMID 23024702 DOI: 10.1016/J.Nantod.2012.06.010 |
0.464 |
|
2012 |
Guo P, Shu Y, Binzel D, Cinier M. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells. Methods in Molecular Biology (Clifton, N.J.). 928: 197-219. PMID 22956144 DOI: 10.1007/978-1-62703-008-3_16 |
0.478 |
|
2012 |
Yang H, Li Q, Lee JH, Shu Y. Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice. International Journal of Biological Sciences. 8: 791-801. PMID 22719219 DOI: 10.7150/ijbs.4568 |
0.388 |
|
2011 |
Shu D, Shu Y, Haque F, Abdelmawla S, Guo P. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics. Nature Nanotechnology. 6: 658-67. PMID 21909084 DOI: 10.1038/Nnano.2011.105 |
0.457 |
|
2011 |
Shu Y, Cinier M, Fox SR, Ben-Johnathan N, Guo P. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1304-11. PMID 21468002 DOI: 10.1038/Mt.2011.23 |
0.469 |
|
2011 |
Shu Y, Cinier M, Shu D, Guo P. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells. Methods (San Diego, Calif.). 54: 204-14. PMID 21320601 DOI: 10.1016/J.Ymeth.2011.01.008 |
0.458 |
|
2011 |
Zhou J, Shu Y, Guo P, Smith DD, Rossi JJ. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods (San Diego, Calif.). 54: 284-94. PMID 21256218 DOI: 10.1016/J.Ymeth.2010.12.039 |
0.333 |
|
2011 |
Liu J, Guo S, Cinier M, Shlyakhtenko LS, Shu Y, Chen C, Shen G, Guo P. Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. Acs Nano. 5: 237-46. PMID 21155596 DOI: 10.1021/Nn1024658 |
0.416 |
|
2011 |
Tarapore P, Shu Y, Guo P, Ho SM. Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 386-94. PMID 21063391 DOI: 10.1038/Mt.2010.243 |
0.412 |
|
2010 |
Guo P, Coban O, Snead NM, Trebley J, Hoeprich S, Guo S, Shu Y. Engineering RNA for targeted siRNA delivery and medical application. Advanced Drug Delivery Reviews. 62: 650-66. PMID 20230868 DOI: 10.1016/J.Addr.2010.03.008 |
0.416 |
|
2009 |
Shu Y, Shu D, Diao Z, Shen G, Guo P. Fabrication of Polyvalent Therapeutic RNA Nanoparticles for Specific Delivery of siRNA, Ribozyme and Drugs to Targeted Cells for Cancer Therapy. Ieee/Nih Life Science Systems and Applications Workshop. Ieee/Nih Life Science Systems and Applications Workshop. 2009: 9-12. PMID 21243099 DOI: 10.1109/LISSA.2009.4906696 |
0.383 |
|
Show low-probability matches. |